Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova Partners
December 14, 2021 03:00 ET
|
MEIOGENIX
Paris, France, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced...
DNAtix Launches a First Pilot of an Anonymous Blockchain Based Full Genome Sequencing
July 09, 2018 16:48 ET
|
DNAtix
CALABASAS, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Digital DNAtix Ltd., the genetics blockchain company, today announced the pilot of a breakthrough blockchain-based infrastructure and ecosystem...
DNAtix Successfully Transferred Craig Venter’s Y Chromosome Using IBM Blockchain
June 29, 2018 03:01 ET
|
DNAtix
TEL-AVIV, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- Digital DNAtix Ltd., the genetics blockchain company, announced the first successful transfer of a complete chromosome using blockchain...
Chronix Biomedical and Hemispherx Biopharma Jointly File Patent Application for a Blood Test for Chronic Fatigue Syndrome (CFS)
March 03, 2011 10:00 ET
|
Hemispherx Biopharma, Inc.
Chronix Technology Focuses on Changes to CFS Patients' DNA
Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS
SAN JOSE, Calif., March 3, 2011...